$856 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 65 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 43.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Sell | MERCK & CO INC | $45,811,000 | -20.1% | 720,982 | -26.0% | 5.35% | -15.8% |
| JNJ | New | JOHNSON & JOHNSON | $42,640,000 | – | 342,350 | +100.0% | 4.98% | – |
| PFE | Sell | PFIZER INC | $39,320,000 | -31.4% | 1,149,372 | -34.9% | 4.59% | -27.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES | $36,849,000 | +27.1% | 851,019 | +13.6% | 4.30% | +34.0% |
| NVS | New | NOVARTIS AGsp adr | $35,077,000 | – | 472,296 | +100.0% | 4.10% | – |
| CELG | Sell | CELGENE CORP | $33,853,000 | -32.6% | 272,066 | -37.3% | 3.95% | -29.0% |
| ABMD | Buy | ABIOMED INC | $32,764,000 | +15.7% | 261,691 | +4.1% | 3.83% | +21.9% |
| FOLD | Sell | AMICUS THERAPEUTICS | $30,742,000 | +21.3% | 4,311,696 | -15.5% | 3.59% | +27.8% |
| DXCM | Sell | DEXCOM INC | $30,278,000 | -0.5% | 357,341 | -29.9% | 3.54% | +4.9% |
| SHPG | Buy | SHIRE PLCsp adr | $30,260,000 | +12.3% | 173,679 | +9.8% | 3.53% | +18.4% |
| ACHC | Sell | ACADIA HEALTHCARE | $30,128,000 | +2.7% | 691,010 | -22.0% | 3.52% | +8.2% |
| NUVA | Sell | NUVASIVE INC | $29,274,000 | -12.9% | 391,989 | -21.4% | 3.42% | -8.1% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $27,671,000 | -32.1% | 315,233 | -35.9% | 3.23% | -28.5% |
| TDOC | Sell | TELADOC INC | $26,464,000 | +2.2% | 1,058,553 | -32.6% | 3.09% | +7.7% |
| TEVA | New | TEVA PHARMACEUTICALsp adr | $24,190,000 | – | 753,821 | +100.0% | 2.82% | – |
| MYL | New | MYLAN N V | $23,813,000 | – | 610,743 | +100.0% | 2.78% | – |
| PTLA | Sell | PORTOLA PHARMACEUTICALS | $23,672,000 | -25.7% | 604,041 | -57.4% | 2.76% | -21.7% |
| ACAD | Sell | ACADIA PHARMACEUTICALS | $23,073,000 | -32.0% | 671,113 | -43.0% | 2.70% | -28.3% |
| ISRG | Sell | INTUITIVE SURGIC INC | $21,976,000 | -18.3% | 28,672 | -32.4% | 2.57% | -13.9% |
| EW | New | EDWARDS LIFESCIENCE | $18,859,000 | – | 200,479 | +100.0% | 2.20% | – |
| WMGI | Buy | WRIGHT MED GROUP N V | $18,088,000 | +71.5% | 581,222 | +26.6% | 2.11% | +80.8% |
| AERI | Buy | AERIE PHARMACEUTICALS | $17,660,000 | +98.3% | 389,423 | +65.5% | 2.06% | +108.9% |
| KTWO | Buy | K2M GROUP HOLDINGS | $17,157,000 | +450.8% | 836,520 | +438.1% | 2.00% | +480.9% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS | $14,833,000 | +6.5% | 713,119 | +6.5% | 1.73% | +12.3% |
| NXTM | Sell | NXSTAGE MEDICAL | $13,538,000 | -42.0% | 504,568 | -43.4% | 1.58% | -38.9% |
| Buy | NEURODERM LTD | $12,990,000 | +32.7% | 489,267 | +11.0% | 1.52% | +39.9% | |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL | $12,869,000 | -60.7% | 1,279,247 | -39.2% | 1.50% | -58.6% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS | $12,735,000 | -21.7% | 345,582 | -69.3% | 1.49% | -17.5% |
| ARAY | Sell | ACCURAY INC | $11,792,000 | -16.6% | 2,482,621 | -19.2% | 1.38% | -12.1% |
| IART | Buy | INTEGRA LIFESCIENCE | $8,531,000 | +43.7% | 202,499 | +192.6% | 1.00% | +51.4% |
| ENDP | New | ENDO INTL PLC | $8,148,000 | – | 730,150 | +100.0% | 0.95% | – |
| PRTA | Buy | PROTHENA CORP PLC | $7,869,000 | +29.4% | 141,046 | +14.1% | 0.92% | +36.4% |
| EVHC | Buy | ENVISION HEALTHCARE | $7,668,000 | -3.1% | 125,050 | +0.0% | 0.90% | +2.1% |
| NVO | Sell | NOVO-NORDISK ASadr | $7,455,000 | -12.1% | 217,480 | -8.0% | 0.87% | -7.2% |
| ADXS | Buy | ADVAXIS INC | $6,861,000 | +38.9% | 839,774 | +21.7% | 0.80% | +46.4% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS | $6,145,000 | +7.6% | 460,300 | +21.3% | 0.72% | +13.4% |
| KITE | Sell | KITE PHARMA INC | $4,986,000 | -70.1% | 63,520 | -82.9% | 0.58% | -68.5% |
| MASI | New | MASIMO CORP | $4,971,000 | – | 53,300 | +100.0% | 0.58% | – |
| RARX | Sell | RA PHARMACEUTICALS | $4,797,000 | +24.9% | 225,340 | -10.9% | 0.56% | +31.5% |
| DBVT | Buy | DBV TECHNOLOGIESsp adr | $4,702,000 | +248.6% | 133,499 | +247.6% | 0.55% | +268.5% |
| LOXO | New | LOXO ONCOLOGY INC | $3,804,000 | – | 90,390 | +100.0% | 0.44% | – |
| MOH | Sell | MOLINA HEALTHCARE | $3,720,000 | -49.9% | 81,575 | -40.4% | 0.43% | -47.3% |
| PTCT | Buy | PTC THERAPEUTICS I | $3,455,000 | +157.3% | 351,135 | +185.2% | 0.40% | +170.5% |
| XLRN | Sell | ACCELERON PHARMA | $3,346,000 | -62.0% | 126,400 | -63.4% | 0.39% | -59.9% |
| BIIB | Sell | BIOGEN INC | $3,202,000 | -86.7% | 11,711 | -86.2% | 0.37% | -86.0% |
| AGIO | Sell | AGIOS PHARMACEUTICALS | $2,990,000 | +30.5% | 51,200 | -6.7% | 0.35% | +37.4% |
| XENT | Sell | INTERSECT ENT INC | $2,457,000 | -62.0% | 143,240 | -73.2% | 0.29% | -60.0% |
| LJPC | New | LA JOLLA PHARMACEUTICAL | $2,349,000 | – | 78,700 | +100.0% | 0.27% | – |
| INCY | Sell | INCYTE CORPORATION | $2,292,000 | -33.5% | 17,145 | -50.1% | 0.27% | -29.8% |
| REGN | New | REGENERON PHARMACEUTICALS | $2,207,000 | – | 5,695 | +100.0% | 0.26% | – |
| INSM | Buy | INSMED INC | $1,937,000 | +41.7% | 110,599 | +7.1% | 0.23% | +49.7% |
| ILMN | New | ILLUMINA INC | $1,937,000 | – | 11,350 | +100.0% | 0.23% | – |
| TGTX | New | TG THERAPEUTICS | $1,602,000 | – | 137,500 | +100.0% | 0.19% | – |
| CRVS | New | CORVUS PHARMACEUTICALS | $1,396,000 | – | 67,200 | +100.0% | 0.16% | – |
| RDY | DR REDDYS LABS LTDadr | $1,291,000 | -11.3% | 32,155 | 0.0% | 0.15% | -6.2% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS | $1,276,000 | +71.3% | 24,899 | +25.1% | 0.15% | +79.5% |
| AVXS | Sell | AVEXIS INC | $1,137,000 | +2.6% | 14,950 | -35.6% | 0.13% | +8.1% |
| CLDX | New | CELLDEX THERAPEUTICS | $914,000 | – | 253,178 | +100.0% | 0.11% | – |
| SAGE | Sell | SAGE THERAPEUTICS | $867,000 | -39.2% | 12,199 | -56.3% | 0.10% | -36.1% |
| SRPT | SAREPTA THERAPEUTICS | $852,000 | +7.8% | 28,799 | 0.0% | 0.10% | +12.5% | |
| OBSV | New | OBSEVA SA | $786,000 | – | 75,500 | +100.0% | 0.09% | – |
| Buy | TRILLIUM THERAPEUTICS | $789,000 | +39.6% | 128,272 | +28.3% | 0.09% | +46.0% | |
| ALBO | New | ALBIREO PHARMA INC | $485,000 | – | 20,224 | +100.0% | 0.06% | – |
| PRFMF | PROFOUND MEDICAL | $387,000 | -6.5% | 495,900 | 0.0% | 0.04% | -2.2% | |
| SRRA | New | SIERRA ONCOLOGY INC | $309,000 | – | 201,660 | +100.0% | 0.04% | – |
| Exit | PRONAI THERAPEUTICS | $0 | – | -201,660 | -100.0% | -0.04% | – | |
| ENTL | Exit | ENTELLUS MED INC | $0 | – | -130,496 | -100.0% | -0.27% | – |
| SCAI | Exit | SURGICAL CARE AFFILIATES | $0 | – | -98,300 | -100.0% | -0.50% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS | $0 | – | -74,150 | -100.0% | -0.89% | – |
| AET | Exit | AETNA INC | $0 | – | -182,185 | -100.0% | -2.50% | – |
| CI | Exit | CIGNA CORP | $0 | – | -212,424 | -100.0% | -3.14% | – |
| LLY | Exit | ELI LILLY & CO | $0 | – | -729,117 | -100.0% | -5.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.